VRBPAC to Review Covid Vaccine Proposals This Week
Posted on January 26, 2023 by Kari Everson
The US Food and Drug Administration (FDA) tasked its Vaccine and other Related Biologicals Advisory Committee (VRBPAC) to review proposals related to COVID-19 vaccines. Items scheduled for review include changing the primary vaccine doses to the bivalent vaccine and whether the composition and schedule for booster doses should be adjusted.
VRBPAC to Review Covid Vaccine Proposals This Week
Members Only
The resource you are trying to access is a Members Only Resource. If you are a member of LeadingAge Minnesota, simply log in. If you forgot your password or aren't sure if you have an account, use the "Forgot your password?" link on the Log In page.
Want to become a member? Click here for further information.
Comments
Add a comment
Members must sign in to comment
You must be a member to comment on this article. If you are already a member, please log in. Not a member? Learn how to join »
No one has commented on this article yet. Please post a comment below.